Cite
HARVARD Citation
Vyas, A. et al. (n.d.). Cisplatin resistance of TMEM16A overexpressing head and neck tumors and cancer models is driven by increased lysosomal flux and reversed by Hydroxychloroquine. European journal of cancer. pp. S112-. [Online].